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Abstract
Despite high burden of dementia in low-and middle-income countries (LMICs),
only a small number of clinical trials of psychosocial interventions for persons
with dementia (PwD) have been conducted in these settings. It is essential that
such trials use appropriate outcome measures that are methodologically
robust and culturally appropriate to evaluate the effectiveness of interventions.
We carried out a systematic review to examine the evidence base and psycho-
metric properties of measures employed in these studies in LMICs. A system-
atic search of published literature on randomised controlled trials (RCT) of
psychosocial interventions for PwD in LMICs between 2008 and April 2020
was carried out. Measures employed in each of the eligible studies were identi-
fied and through a focused search, we further explored the evidence base and
psychometric properties employing Terwee criteria. Data extraction and quality
appraisal were conducted by two independent reviewers. The review identified
41 measures from 17 RCTS which fulfilled eligibility criteria and they examined
effectiveness across the domains of cognition (n = 16), behaviour and psycho-
logical symptoms (n = 11) and quality of life (n = 8). Of these 41, we were able
to access relevant literature only for 18 and they were subject to psychometric
analysis. Psychometric properties of these 18 instruments were at best mod-
est, with Terwee scores ranging from 3 (low) to 15 (moderate). A majority of
the studies were from China (n = 5) and Brazil (n = 6). The evidence base for
the routinely employed measures in RCTs of non-pharmacological interven-
tions for PwD in LMICs is limited. The quality of adaptation and validation of
these instruments is variable and studies are largely uninformative about their
psychometric properties and cultural appropriateness to the study setting.
There is an urgent need to develop scientifically robust instruments in LMIC
settings that can be confidently employed to measure outcomes in trials of
psychosocial interventions for PwD.
INTRODUCTION
Demographic ageing is a global phenomenon and the
most important social transformation of the 21st cen-
tury.1 Of all the chronic non-communicable diseases
(NCDs) related to ageing, dementia and cognitive impair-
ment are the leading contributors to disability, and par-
ticularly, dependence among older people worldwide.2
Worldwide, around 50 million people live with demen-
tia, and this is estimated to reach 75 million by 2030.3
Two in three people with dementia live in low- and
middle-income countries (LMIC).4 This poses a huge
challenge for governments to plan and design viable
assessment and treatment options for persons with
dementia suitable for their countries. In LMIC settings,
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dementia is often seen as part of normal ageing, is
under-recognised, under-disclosed, under-treated, and
under-managed.5 These factors make evaluation, treat-
ment and research on dementia in these settings
uniquely challenging, with specialist and culturally spe-
cific tools, methods for assessment and monitoring of
treatment required.
Considering the aforementioned complexities and
challenges of evaluation and treatment of dementia,
the development of novel, tailor-made therapeutic
interventions is required for LMIC settings. Among all
the interventions available, psychosocial interven-
tions are particularly important and suitable as they
are typically low cost and less resource intensive.
They are more relevant to those settings where
access to medicines and specialists is restricted.
However, in this era of evidence-based medicine,
these novel psychosocial interventions need to be
tested for their feasibility, efficacy and applicability in
local contexts using gold standard randomised con-
trolled trials (RCTs). Selecting appropriate outcome
measures is a critical step in designing valid and use-
ful clinical trials for persons with dementia, as the use
of an unreliable measure may result in important
information about the effectiveness of an intervention
being lost or distorted.6
Choosing an appropriate outcome measure is
even more important in LMIC settings as a significant
number of measures used in intervention trials for
persons with dementia were originally developed in
high income countries (HICs). As there is little
standardisation of methods for adaptation of these
measures, their current ‘adaptation’ varies from
cross-cultural adaptation with adequate methodology
to informal verbatim translation. There is no consen-
sus as to which measures are most appropriate or
psychometrically robust for use in persons with
dementia.
The aims of this systematic review are to:
1 Identify outcome measures that are used to evalu-
ate the effectiveness of psychosocial interventions
for persons with dementia in LMICs
2 Conduct a quality appraisal of the psychometric
properties of each of the outcome measures
3 Provide recommendations for use of outcome




A systematic search of published literature from 2008
to 2019 on psychosocial interventions delivered to
persons with dementia in LMICs was previously con-
ducted by authors of this team.7 Results from this
search consisted of 17 studies, describing 11 interven-
tions in six countries. A repeat search was run in April
2020 using the published search strategy and the pro-
cess of the systematic review is shown in Figure 1.
Each of the studies included in this systematic review
was subject to an additional search to identify relevant
outcome measures used and focused searches were
used to identify articles that described the develop-
ment or adaptation of these measures for the coun-
tries in question. All included measures were subject
to a quality appraisal to determine validity and reliabil-
ity by employing Terwee criteria.8 This systematic
review followed the standard Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines for systematic review and a
checklist for the same has been submitted as a
Appendix S1 for further reading.9
Search strategy
The full search strategy is described in a related
review.7 Briefly, Cochrane Controlled Register of Trials
(CENTRAL), PubMed, EMBASE, PsycINFO and
MEDLINE were searched for studies published
between 2008 and April 2020. Search terms fell under
the categories: psychosocial or non-pharmacological
interventions, LMICs and people with dementia.
LMICs were designated as such according to their
classification by the Organisation for Economic Co-
operation and Development.10 The list of included
studies was then examined and all outcome mea-
sures for cognitive, psychological and social
domains were extracted. The reference list was then
examined to identify articles that described the
development of these measures for the country in
question or, if it was an existing measure, the article
that described the translation and adaptation of the
measure for the country in question. These articles
are subsequently described as ‘measure develop-
ment or adaptation papers’ and were included
regardless of publication date. In cases where the
reference given was for an English language
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measure but not for the translated or adapted ver-
sion, the corresponding author was contacted to
ascertain which version of the measure was used.
Inclusion and exclusion criteria
A measure development or adaptation paper was
included if:
Figure 1 Process of systematic review (flow chart).
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1 The domain measured was deemed by authors to
be cognitive, psychological or social in nature
2 The outcome measure was used in an intervention
study to examine change over a period of time in
persons with dementia, as an indicator of benefit
derived from the intervention
3 It was published in a peer-reviewed journal.
A measure development or adaptation paper was
excluded if:
1 It was published in a language other than English
and an English translation was not available.
Quality assessment
Included measures were grouped by domain (cogni-
tion, behaviour, depression, anxiety and quality of life)
and a quality assessment was undertaken indepen-
dently by two authors (BD and ML) against the Terwee
criteria,8 used successfully in related reviews.11, 12 The
Terwee criteria are based on a list of nine common
psychometric properties: content validity, internal con-
sistency, criterion validity, construct validity, reproduc-
ibility, responsiveness, floor and ceiling effects and
interpretability and, for each domain listed, a maxi-
mum score of two was awarded if the psychometric
properties were correctly evaluated and were within
an acceptable range. A score of one per criterion was
awarded if the methodology reported was flawed and
zero was awarded if no information was reported or
psychometric properties reported fell outside the
acceptable range. Full criteria are provided in Table 1.
After the initial appraisal, authors BD and ML dis-
cussed their ratings and any discrepancies until a con-
sensus was reached.
RESULTS
Our search yielded 17 intervention studies from six
LMICs. Studies were conducted in Brazil (n = 6),
China (n = 5), India (n = 2), Tanzania (n = 2), Turkey
(n = 1) and Argentina (n = 1). A wide range of inter-
ventions were evaluated: reality orientation, cognitive
stimulation therapy (CST), reminiscence therapy,
music therapy, tailored rehabilitation programs,
games and other activities were used for the treat-
ment of dementia. Forty-one outcome measures
were identified, of which 16 were primarily measures
of cognition, three measured behavioural and psy-
chological symptoms or distress in dementia, eight
measured depression and anxiety, eight measured
quality of life, four measured caregiver burden and
two measured disability.
Only 18 outcome measures were included for psy-
chometric analysis, as 23 had to be excluded for the
following reasons: there was no evidence of valida-
tion or adaptation of the chosen outcome measure
for the study setting (n = 13), inability to access the
full articles (n = 3), scale measured other outcomes
related to caregivers (n = 4) and the validation studies
were not in English language (n = 3).
Most authors had provided the citation of the orig-
inal development article of an outcome measure in
English, but these studies lacked information related
to cultural adaptation of the outcome measure for
use in the study setting. For example, many authors
referenced Folstein et al., 1975 for Mini Mental Status
Examination (MMSE), which is an original develop-
ment article.13 It is likely that many would have used
a verbatim translated outcome measure (informal lin-
guistic translation) instead of a systematically trans-
lated, adapted and validated measure (cultural
adaptation) for study population and settings. Hence,
we contacted the corresponding authors of all the eli-
gible studies by email to obtain further clarification
about the measures they had employed in their
study, including the references for those measures. If
no response was received after 2 weeks of initial
contact, we sent them another email reminder. How-
ever, only three of the 17 authors (Li, Asiret and
Camargo) replied. Li and colleagues had used lin-
guistically translated (without formal adaptation and
validation) outcome measures which were widely in
use in China, while Asiret and Camargo had used
culturally adapted and validated scales in Turkish
and Portuguese languages respectively but had
referenced original English developmental articles of
the outcome measure. After discussing as a team,
we decided to assume that authors who did not
respond were likely to have used either a culturally
adapted or verbatim translated version of the original
outcome measure. Hence, for the purpose of this
review, further searches were undertaken to identify
the culturally adapted and validated version of mea-
sures specific to each country.
A summary of all the 17 intervention studies is
given in Table 2. Psychometric properties of the out-
come measures are described below and ratings of
these measures based on Terwee criteria ARE
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Table 1 Terwee criteria
Property Definition Quality criteria
1 Content validity The extent to which the domain of interest is
comprehensively sampled by the items in the
questionnaire (the extent to which the measure
represents all facets of the construct under
question).
+2 A clear description of measurement aim, target
population, concept(s) that are being
measured, and the item selection AND target
population (investigators OR experts) were
involved in item selection.
?1 A clear description of the above-mentioned
aspects in lacking OR only target population
involved OR doubtful design or method.
−0 No target population involvement.
00 No information found on target population
involvement.
2 Internal consistency The extent to which items in a (sub)scale are
inter-correlated, thus measuring the same
construct.
+2 Factor analyses performed on adequate sample
size (7* # items and ≥ 100) AND Cronbach’s
alpha(s) calculated per dimension AND
Cronbach’s alpha(s) between 0.70 and 0.95
?1 No factor analysis OR doubtful design or method
−0 Cronbach’s alpha(s) <0.70 or > 0.95, despite
adequate design and method
00 No information found on internal consistency
3 Criterion validity The extent to which scores on a particular
questionnaire relate to a gold standard
+2 Convincing arguments that gold standard is
‘gold’ AND correlation with gold standard
≥ 0.70
?1 No convincing arguments that gold standard is
‘gold’ OR doubtful design or method
−0 Correlation with gold standard <0.70, despite
adequate design and method
00 No information found on criterion validity
4 Construct validity The extent to which scores on a particular
questionnaire relate to other measures in a
manner that is consistent with theoretically
derived hypotheses concerning the concepts
that are being measured
+2 Specific hypotheses were formulated AND at
least 75% of the results are in accordance with
these hypotheses
?1 Doubtful design or method (e.g. no hypotheses)
−0 Less than 75% of hypotheses were confirmed,
despite adequate design and methods
00 No information found on construct validity
5 Reproducibility
5.1 Agreement The extent to which the scores on repeated
measures are close to each other (absolute
measurement error)
+2 SDC < MIC OR MIC outside the LOA OR
convincing arguments that agreement is
acceptable
?1 Doubtful design or method OR (MIC not defined
AND no convincing arguments that agreement
is acceptable)
−0 MIC ≤ SDC OR MIC equals or inside LOA despite
adequate design and method
00 No information found on agreement
5.2 Reliability The extent to which patients can be distinguished
from each other, despite measurement errors
(relative measurement error)
+2 ICC or weighted Kappa ≥ 0.70
?1 Doubtful design or method
−0 ICC or weighted Kappa <0.70, despite adequate
design and method
00 No information found on reliability
6 Responsiveness The ability of a questionnaire to detect clinically
important changes over time
+2 SDC or SDC < MIC OR MIC outside the LOA OR
RR > 1.96 OR AUC ≥ 0.70
?1 Doubtful design or method
−0 SDC or SDC ≥ MIC OR MIC equals or inside LOA
OR RR ≤ 1.96 or AUC <0.70, despite adequate
design and methods
00 No information found on responsiveness
7 Floor and ceiling
effects
The number of respondents who achieved the
lowest or highest possible score
+2 ≤ 15% of the respondents achieved the highest
or lowest possible scores
B. Du et al.
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tabulated in Table 3 and a further summary of their
validation studies is given in Appendix S1.
OUTCOME MEASURES RELATED TO
COGNITION
A total of eight scales that measure cognition
were included. The Chinese Montreal Cognitive
Assessment Basic (MoCA- BC) scored most robustly
on psychometric properties with a score of 15/18.
Alzheimer’s Disease Assessment Scale – Cognitive
sub-Saharan Africa (ADAS-Cog SSA - 10/18), the
Revised Turkish MMSE (r MMSE –Turkish- 10/18)
and the Short Cognitive Test (SKT Brazil version –
9/18) showed moderate score on psychometric anal-
ysis while Toronto Alexithymia Scale 20 Chinese
(TAS 20 Chinese - 7/18), Consortium to Establish a
Registry for Alzheimer’s Disease- neuropsychological
battery (Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) Brazil - 7/18), MMSE-
Brazil (6/18) and Chinese adapted MMSE (6/18)
scored poorly.
Chinese version of MoCA-BC
The MoCA basic (MoCA-B) was developed by
Nasreddine (1996) in Canada to screen for MCI in illit-
erate individuals and those with little education.31, 49
The Chinese version of the MoCA-B (MoCA-BC) was
translated from the original English version. The
MoCA-BC was reported to have good content validity
and criterion-related validity (Pearson correlation coef-
ficient of MoCA-BC vs. MMSE = 0.787) and reliable
internal consistency (Cronbach’s α = 0.807). This scale
showed good responsiveness, with the area under the
receiver operating characteristic (ROC) curve more
than 0.8 across all education levels in Chinese older
adults. Inter-rater reliability was also excellent with
intraclass coefficient value of 0.96 (P < 0.001).31
Alzheimer’s Disease Assessment Scale –
Cognitive subscale for sub-Saharan Africa-
ADAS-Cog SSA
The ADAS-Cog was developed in the 1980s to assess
the level of cognitive dysfunction in Alzheimer’s dis-
ease (AD), but its use has extended into pre-dementia
studies despite concerns about its ability to detect
important changes at these milder stages of disease
progression.32, 50 One team adapted the ADAS-Cog
for use in sub-Saharan African settings with low liter-
acy levels. The area under the ROC curve as 0.973
(95% CI = 0.936–1.00) for dementia, indicating good
responsiveness of the scale. Internal consistency was
high (Cronbach’s α = 0.884) and inter-rater reliability
was excellent (intraclass correlation coefficient (ICC)
0.905, 95% CI 0.804–0.964). The scale also showed
excellent content and criterion validity with convincing
arguments and demonstration of strong correlation
with severity of dementia measured with Clinical
Dementia Rating Scale (CDR).32
Short Cognitive Performance Test Brazilian
version-SKT Brazil
The SKT is a bedside cognitive screening battery
designed to detect memory and attention deficits.34, 51
Table 1 Continued
Property Definition Quality criteria
?1 Doubtful design or method
−0 >15% of the respondents achieved the highest or
lowest possible scores, despite adequate
design and methods
00 No information found on interpretation
8 Interpretability The degree to which one can assign qualitative
meaning to quantitative scores
+2 Mean and SD scores presented of at least four
relevant subgroups of patients and MIC
defined
?1 Doubtful design or method OR less than four
subgroups OR no MIC defined
00 No information found on interpretation
In order to calculate a total score + = 2;? = 1; − = 0; 0 = 0 (scale of 0–s18). SDC, smallest detectable difference (this is the smallest within person change,
above measurement error. A positive rating is given when the SDC or the limits of agreement are smaller than the MIC); MIC, minimal important change (this is
the smallest difference in score in the domain of interest which patients perceive as beneficial and would agree to, in the absence of side effects and excessive
costs); SEM, standard error of measurement; AUC, area under the curve; RR, responsiveness ratio; LOA, limits of agreement.
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Flaks and colleagues have validated a Brazilian version
of the SKT and reported the area under ROC ranging
between 0.7 and 1, suggesting that the SKT ade-
quately discriminates AD from participants without
dementia (MCI and controls), irrespective of education.
Inter-rater and test–retest agreement, floor and ceiling
effects were not reported by the authors. However,
authors have mentioned that the preliminary study in
Brazil showed good internal consistency, with
Cronbach’s α equal to 0.8 and significant correlation
with MMSE and the CDT (clock drawing test).34
Toronto Alexithymia Scale 20 Chinese version
-TAS 20-Chinese
Bagby and colleagues developed TAS 20 in 1994
from an earlier 26 item version developed by
them.36, 52 It has three subscales: Difficulty Describ-
ing Feelings to others (DDF), Difficulty Identifying
Feeling (DIF) and Externally-Oriented Thinking (EOT)
designed to measure deficiency in understanding,
processing, or describing emotions. Zhu and col-
leagues translated the TAS to Chinese with involve-
ment of Chinese psychologists and developers of the
original English TAS and reported good content
validity. Confirmatory factor analysis was conducted,
which showed that a three factor model showed best
acceptable standards and a Cronbach’s alpha >0.7
showed high internal consistency. Test–retest coeffi-
cient for the whole scale together and subscales
were >0.7 showing good test–retest reliability. How-
ever, there was no information on criterion validity,
construct validity, responsiveness, floor and ceiling
effects or inter-rater agreement in the article.36
CERAD – Brazil version
The CERAD was funded in 1986 by the National Insti-
tute on Ageing to develop a standardised assess-
ment tool of AD for use by all Alzheimer Disease
Centres established in the United States.35, 53 It con-
sists of a clinical battery, neuropsychological battery,
neuroimaging battery, family history scale, behav-
ioural problems scale, family history assessment, ser-
vices assessment, autopsy resources and
educational brochures. Bertolucci and colleagues
evaluated its validity in Brazil and reported that all the
tests in CERAD had good sensitivity and specificity
ranging from 73–97% and 67–87% respectively, with
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sensitivity of 61% and Constructional Praxis with
specificity of 51%. All the tests showed good
responsiveness with areas under ROC curve ranging
between 0.7 and 0.9. However, internal consistency,
criterion validity, test–retest reliability, inter-rater reli-
ability, floor and ceiling effects have not been
reported.35
MMSE
Folstein and his colleagues formulated the MMSE, a
30-point psychological tool for measuring cognitive
impairment.13 Since then it has been adapted to mul-
tiple languages and regions and extensively used in
clinical and research settings.54 In this review, three
culturally adapted MMSE scales were evaluated.
Revised MMSE Turkey version – r MMSE-T
The authors reported areas under ROC curve in edu-
cated and uneducated older people to be 0.953 and
0.907 respectively, which indicates good responsive-
ness of the outcome measure in detecting clinically
important change in cognitive function over time.33
The scale had good content validity, internal consis-
tency, inter-rater and intra-rater agreement with
Cronbach’s α and kappa values higher than 0.7 for
both educated and uneducated older people. Cut-off
point of 22/23 of r MMSE-T in the educated older
people had the highest sensitivity (90.9), specificity
(97.0) and positive likelihood ratio (30.3), whereas
cut-off point of 18/19 of the test in uneducated older
people had the highest sensitivity (82.7%), specificity
(92.3%) and positive likelihood ratio (10.7). Construct
validity, floor and ceiling effects of the scale have not
been reported.33
MMSE-Brazil version - MMSE-Brazil
A modified translated Portuguese version of the
MMSE, proposed by Bertolucci and colleagues in
1994 and Almeida and colleagues in 1998 was used
in this validation study.37, 55, 56 The authors involved
geriatricians in item selection during measure adapta-
tion and reported good content validity. Sensitivity,
specificity, positive and negative predictive values
were 80.8%, 65.3%, 44.7% and 90.7% respectively
for a cut-off point of 23/24. The area under the ROC
curve was 0.807, indicating good responsiveness.
Criterion validity has been tested with diagnosis of
dementia by geriatricians using structured interviews
based on Diagnostic and Statistical Manual 4th
edition (DSM-IV) and International Classification of
Diseases Edition 10 (ICD-10). However, information
on other psychometric measures such as internal
consistency, inter-rater agreement, test–retest reli-
ability, construct validity, responsiveness and floor
and ceiling effects was lacking.37
Chinese adapted MMSE – CAMSE
The CAMSE was adapted from the original MMSE
with some changes in test items to minimise literacy
dependency and render them compatible with Chi-
nese culture, while the main structures of the original
test were kept intact and similar principles for scoring
were used as much as possible.38 This suggests that
the CAMSE tests the same cognitive functions as the
original MMSE. Literate participants scored a higher
CAMSE total score than illiterate participants
(P < 0.05) to yield optimal cut-off points of 22 for lit-
erates and 20 for illiterates with a sensitivity of
83.87% and a specificity of 84.48%. Corresponding
positive predictive value (PPV) was 0.65, and nega-
tive predictive value (NPV) was 0.94. The test–retest
reliability tested after 4–6 weeks for total scores was
0.75 (P < 0.01). However, the article lacked informa-
tion on internal consistency, criterion validity, con-
struct validity, responsiveness, floor and ceiling
effects and interpretability of the scale.
OUTCOME MEASURES RELATED TO
BEHAVIOURAL AND PSYCHOLOGICAL
SYMPTOMS IN DEMENTIA (BPSD)
NPI - Neuro-Psychiatric Inventory
The NPI is a tool which measures behavioural distur-
bances in dementia using two separate scales for rat-
ing the severity of each symptom and the distress
caused to the caregiver respectively.57 It was origi-
nally developed by Cummings et al. in 1994.57 This
scale was used in eight studies across three coun-
tries – Brazil, China and Tanzania. Adaptation studies
of NPI Brazil and China versions are reviewed here,
while adaptation to Tanzania could not be traced.
NPI - Brazil
This tool received a Terwee score of 9 and reported
test–retest reliability (Spearman’s rho for total sever-
ity = 0.82), internal consistency (Cronbach’s α = 0.7
for both severity and distress scales) and inter-rater
B. Du et al.
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reliability (ICC severity = 0.98, distress = 0.96).39 It
also provided ample information on content validity
for the Portuguese translation, and both ceiling and
floor effects for some items. It was one of the few
papers that provided some information on floor and
ceiling effects. However, it was uninformative on cri-
terion validity, construct validity or responsiveness.39
NPI - Brazil- clinician version
This adapted tool scored 8/18 on the Terwee scale
as it lacked information on internal consistency,
agreement, responsiveness and floor and ceiling
effects.40 The validation focused mostly on inter-rater
reliability (ICC of 0.923) and convergent validity with
seven other scales, each of which measure various
behavioural problems in dementia, with a sample of
156 participants. Convergent validity with the Apathy
Inventory, Cohen-Mansfield agitation index, Cornell
Scale for depression in dementia and Brief Psychiat-
ric Rating scale – delusions was high (Pearson corre-
lation r ≥ 0.7) but was poor with Brief Psychiatric
Rating Scale – hallucinations (r = 0.432). Even though
the authors mentioned conducting test–retest reliabil-
ity analysis, the results were not reported in the
paper.40
Chinese NPI – CNPI
This tool scored 7 on the Terwee scale and had clear
information on content validity, internal consistency
(Cronbach’s α = 0.69 for the severity and 0.72 for the
caregiver distress scale) and agreement (test–retest
correlation coefficient between 0.66 and 0.98).41
Construct validity was also analysed through the
Kaiser-Meyer-Olkin value which confirmed that there
were five common factors present within the tool. Of
note, there were no clear hypotheses tested in the
paper.41
OUTCOME MEASURES RELATED TO
DEPRESSION AND ANXIETY
Hospital Anxiety and Depression Scale -
Chinese version - HADS Chinese
The HADS was originally developed by Zigmond and
Snaith (1983) to screen for depression and anxiety in
general hospital patients.42 Leung and colleagues
validated a Chinese-Cantonese version of the HADS
against the Hamilton Rating Scale of Depression
(HRSD) and Hamilton Rating Scale of Anxiety (HRSA)
and reported good internal consistency (Cronbach’s
α = 0.86) and concurrent validity (Pearson’s coeffi-
cient = 0.67 and 0.63, respectively; P < 0.001) with
favourable sensitivity (0.79; 95% CI = 0.66–0.90) and
specificity (0.80; 95% CI = 0.69–0.91) for screening
for psychiatric disorders. However, its performance
was marginally inferior to that of the HRSD. The
authors did not report test–retest reliability, inter-rater
agreement, floor and ceiling effect and hence scored
moderately (8/18) on Terwee criteria. As the valida-
tion has been done in a general population, this
questions its applicability in dementia research.42
Geriatric Depression Scale Brazil - 30 item
version - GDS 30 Brazil and 15 item version -
GDS 15 Brazil
GDS was originally developed in 1983 by
Yesavage.43, 44, 58 The original 30 item version of the
GDS has been shortened and separately adapted
and validated into scales with 15, 10, four and one
item(s) across many languages and cultures.
Two studies from Brazil have validated the GDS
for use in the local community. Paradela and col-
leagues validated the shortened GDS-15 version with
a geriatric population.44 This study obtained a
Terwee score of 6/18, while Castelo et al. validated
GDS 30 and scored 7/18 points on the Terwee scale.
Both studies reported on the content validity ade-
quately (with description on translation and back
translation by experts), criterion validity (against
DSM-IV criteria based diagnosis provided by a
trained clinician) and responsiveness (area under the
curve value above 0.9).43, 44 Castelo et al. validated
all versions of the GDS (30, 15, 10, four and one) and
additionally reported on internal consistency
(Cronbach’s α = 0.7 or above in all of the tools).43
Both lacked information on construct validity, test–
retest and inter-rater agreement, floor and ceiling
effects and interpretability.43, 44
OUTCOME MEASURES RELATED TO
QUALITY OF LIFE (QOL)
Four measures examined QOL in persons with
dementia. The Chinese Short Form health survey-36
(SF-36) scored 10/18 and World Health Organization
QOL assessment scale brief (WHOQOL- BREF)
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scored 9/18, while the Brazilian version of the QOL -
Alzheimer’s disease (QOL-AD) scored 8/18 and
WHOQOL-Hindi scored only 3/18.
Chinese Short Form health survey-36 - SF-36/
RAND 36 Chinese
The SF-36 was developed as part of a medical out-
comes study.45, 59 Li et al. in 2003 adapted and vali-
dated it for Chinese use. The content validity was
found to be good with a clear description of mea-
surement aim, target population, concept being mea-
sured and involvement of target population in item
selection. Convergent validity and discriminant valid-
ity were satisfactory for all except the social function-
ing scale. The Cronbach’s α coefficient ranged from
0.72 to 0.88 except 0.39 for the social functioning
scale and 0.66 for the vitality scale. Test–retest reli-
ability coefficients (at 2 weeks) ranged from 0.66 to
0.94. Factor analysis identified two principal compo-
nents explaining 56.3% of the total variance. Inter-
rater reliability, responsiveness and floor and ceiling
effects were not reported.45
QOL for patients with AD Brazilian version -
QOL-AD Brazil
Logsdon et al. proposed the QOL-AD, which has
three versions: two addressing the patient’s QOL:
one for the patient himself/herself (PQOL) and
another for the caregiver perception of patient’s
QOL- CPQOL), and a third related to the QOL of the
Caregiver- (CQOL).47, 60 The QOL-AD has been
translated and adapted to Portuguese by Novelli
et al. Authors reported Cronbach’s α of more than
0.8 for all the three versions. Content validity and
construct validity were found to be good with con-
vincing arguments for the same. Criterion validity
was not determined as there was no instrument avail-
able for evaluation of QOL in dementia in Portuguese.
The authors did not report test–retest and inter-rater
reliability, responsiveness, floor and ceiling effects.47
WHO QOL assessment scale brief - WHOQOL-
BREF and WHOQOL-Hindi
WHOQOL-BREF has been derived from the WHOQOL-
100 tool, which was developed by the WHOQOL
Group in 15 international field centres as a cross-
culturally applicable QOL assessment tool.46, 48, 61, 62
The authors reported high correlations ranging from
0.89 to 0.95 between domain scores based on the
WHOQOL-100 and WHOQOL-BREF. Cronbach’s α
ranged from 0.66 to 0.84 demonstrating good internal
consistency. Content validity and test–retest reliability
(range from 0.66 to 0.87) was good, while discriminant
validity was excellent. However, inter-rater reliability,
responsiveness and floor and ceiling effects were not
reported.46
WHOQOL-Bref Hindi was developed in Delhi, one
of the 15 centres in the WHOQOL study. The authors
reported that the Hindi version and other national
versions were compatible and comparable, as the
WHOQOL was developed simultaneously in many
centres across the world. However, the article was
uninformative about the psychometric properties of
WHOQOL-Bref Hindi.48
DISCUSSION
Eighteen outcome measures related to persons with
dementia were identified (covering the constructs of
cognition, behavioural and psychological symptoms,
QOL, anxiety and depression) from 17 psychosocial
intervention studies in LMICs. All of these were cul-
turally adapted and validated versions from an origi-
nal English measure, indicating a lack of indigenously
developed measures in the native language/s of
LMIC. Most measures achieved a modest score on
their adaptation procedures, with the MoCA-Chinese
version scoring highest (15/18) and the WHOQOL-
Bref Hindi scoring the lowest (3/18) on Terwee
criteria.
In intervention studies involving persons with
dementia, the most commonly employed indicators
of effectiveness are measures of cognition. Of the
nine outcome measures for cognition, the MoCA-BC
(Chinese) was the most robustly developed, while the
SKT Brazil version, ADASCOG-SSA and r MMSE-T
gave moderate results on psychometric analysis.
These tools appear to be adequate measures of cog-
nition in patients with dementia. The TAS 20 Chinese
version, CERAD Portuguese version, CAMSE and
MMSE-Brazil version scored low on psychometric
analysis and need further psychometric examination
before they can be used routinely. All the cognition
measures were validated in geriatric populations
except TAS 20 Chinese version, which has been vali-
dated in undergraduate students.
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BPSD form another important dimension of
dementia research. The NPI is one of the most widely
used tools for evaluating BPSD and all the three ver-
sions - NPI Brazil clinician version, NPI Brazil version
and NPI Chinese version - have been developed with
moderate robustness and are adequate to detect and
measure BPSD. However, further adaptation and vali-
dation of NPI to other languages and regions of LMIC
is essential. The HADS Chinese, GDS 30 Brazil and
GDS 15 Brazil used to measure anxiety, depression
in hospital patients and depression in geriatric popu-
lation respectively, have been developed with moder-
ate robustness. However, the HADS Chinese is
validated for general hospital patients and its validity
for research in dementia is questionable and requires
further psychometric examination before it can be
routinely used with confidence.
Quality of life is a more recent but firmly
established theme in dementia research, facilitating
an integrative model for dementia treatment and
care. The QOL-AD Brazil, WHOQOL-Bref and Chi-
nese SF-36 appear to be adequate measures of
QOL, while WHOQOL-Bref Hindi appears to be a
poor measure of QOL as the authors did not report
most psychometric parameters. The Chinese SF-36
and WHOQOL have been validated in general
populations and their validity for research in dementia
is questionable and requires further psychometric
examination before they are routinely used.
Many studies had not used adequate methodol-
ogy for transcultural adaptation of an outcome mea-
sure, instead used an informally translated measure
for validation. Cultural adaptation of a tool involves
the production of an equivalent instrument for a tar-
get population, one that measures the same phe-
nomenon in the original and the target cultures,
rather than a verbatim translation. The first phase of
the process includes a translation of words and sen-
tences from the original language to another and then
further linguistic adaptation to the cultural context of
the target population to ensure that the new version
is conceptually and culturally pertinent. The second
phase of the cultural adaptation includes a validation
phase during which the instrument is proven to be
psychometrically equivalent to the original version.63,
64 Even when translated versions are in a
population’s native language, there can be cultural
differences in the verbal expression of concepts, in
meaning, and in relevance that may affect confidence
in the validity of results obtained using the transla-
tion.65 Furthermore, a verbatim translated measure of
cognition would increase the possibility of false posi-
tive rates of dementia as participants undergoing the
test might skip or give wrong answers due to lack of
understanding of the questions and alien concepts of
the test, rather than cognitive deficits. This highlights
the need for use of transcultural adaptation of out-
come measures with adequate methodology in place
of informal linguistic translations.
METHODOLOGICAL ISSUES AND
LIMITATIONS
All the measures included here failed to define mini-
mal important change, which is a requisite of Terwee
criteria for interpretability and responsiveness. Except
for MoCA-BC, no other validation study reported the
floor and ceiling effects. This meant scoring the mea-
sures for interpretability and floor and ceiling effect
was nearly impossible. Even though most authors
reported Cronbach’s alpha, they failed to report infor-
mation on factor analysis performed on adequate
sample size, leading to poor scores on internal con-
sistency. We also noted that many authors had
reported sensitivity, specificity, PPV and NPV in their
validation papers, but these statistical tools are not
included in the Terwee criteria. This suggests that
researchers consider sensitivity and specificity as
important tools to be tested in a validation study and
further hints toward the need for a more inclusive and
comprehensive psychometric criterion, which
includes sensitivity and specificity of outcome mea-
sures in the psychometric analysis.
Referencing in scientific literature is very important
as it gives the readers an understanding of the
source of the information and also enables them to
find the source of information for further reading if
necessary. However, if the standard guidelines for
referencing are not adhered in scientific articles, it
undermines the purpose of referencing. In this
review, we found many researchers citing the refer-
ence of an original development article of the out-
come measure instead of the actual culturally
adapted and validated version used in the research
work in the country in question. Furthermore, some
validation studies for these outcome measures were
difficult to locate and could only be located by exten-
sive searching. Also, many outcome measures had
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to be excluded from the review as adapted versions
could not be found despite exhaustive searching.
This warrants a need to promote and sensitise
researchers about standard referencing guidelines.
Although we employed broad search criteria to
identify potentially eligible studies, it is still possible
that we may have missed out some studies due to
heterogeneous nature of reporting changes in psy-
chosocial interventions studies among persons with
dementia.
IMPLICATIONS FOR RESEARCH AND
PRACTICE
Our review highlights the need for researchers to
examine and ensure appropriate psychometric prop-
erties of outcome measures to be included in their
research, while designing the research protocol and
use outcome measures designed for a specific popu-
lation, for a particular age group, region, culture and
language to avoid skewed results and for better
applicability of results in the population in question.
Researchers should also provide references to the
specific adapted version of an outcome measure cor-
rectly, in addition to referencing an original outcome
measure developed in a different study setting. This
review highlights limited availability of indigenously
developed, culturally appropriate and validated out-
come measures in LMIC, which may have inadver-
tently led the investigators of the studies included in
this systematic review to use verbatim translated
instruments. Even though most studies included in
this review reported statistically significant effect of
the intervention across domains of cognition, psy-
chological symptoms and QOL, little is known about
its clinical effectiveness.
This review indicates that MoCA-BC (for cognition)
and Chinese SF-36 (for QOL), SKT Brazil version (for
cognition) and NPI Brazil (for BPSD), ADASCOG-SSA
(for cognition) and r MMSE-T (for cognition) can be
used in dementia research with confidence in China,
Brazil, sub-Saharan Africa and Turkey respectively.
Researchers should be aware of lack of psychologi-
cal robustness of other outcome measures evaluated
here. We suggest researchers exercise caution about
the psychometric properties of outcome measures
while choosing outcome measures for their research
pursuits and, also while interpreting results of an
intervention study from a LMIC setting. LMICs are
characterised by populations with distinctively differ-
ent cultures and spoken languages that are specific
to a region within a country, which limits the
generalisability and applicability of outcome mea-
sures and results of an intervention study beyond the
study setting. Therefore, the first step in planning an
intervention study for persons with dementia in
LMICs should be to develop culture and context spe-
cific measures in their language/s and establish their
psychometric properties.
CONCLUSION
The evidence base for the routinely employed mea-
sures in RCTs of non-pharmacological interventions
for persons with dementia in LMICs is limited. The
quality of adaptation and validation of these instru-
ments is variable and studies are largely uninforma-
tive about their psychometric properties and cultural
appropriateness to the study setting. There is an
urgent need to develop scientifically robust instru-
ments in LMIC settings that can be confidently
employed to measure outcomes in trials of psycho-
social interventions for persons with dementia.
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